The use of umbilical cord blood as a cellular source for correction of genetic diseases affecting the hematopoietic system

Stem Cells
D W Clapp, D A Williams

Abstract

Human umbilical cord blood contains abundant primitive and committed hematopoietic progenitors and has been used as an alternative source of reconstituting hematopoietic stem cells. Recent advances in the understanding of molecular aspects of multiple diseases and improvements in technology associated with prenatal diagnosis now allow the in utero identification of many genetic diseases affecting the hematopoietic system. Advances in technology raise the potential for genetic correction and subsequent transplantation of autologous cord and placental blood hematopoietic stem cells into affected patients prior to expression of the disease phenotype. This review will summarize the recent data on advances in prenatal diagnosis, characterization of the biology of cord blood stem cells, and efforts at developing methods for genetic transduction of cord blood hematopoietic stem/progenitor cells.

References

Sep 27, 1976·JAMA : the Journal of the American Medical Association
Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·V W van BeusechemD Valerio
Sep 24, 1992·The New England Journal of Medicine·J L Simpson, S A Carson
May 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·H J SutherlandC J Eaves
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·H E BroxmeyerE A Boyse
Nov 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·B LimD A Williams
Nov 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D M BodineA W Nienhuis
Dec 1, 1988·Molecular and Cellular Biology·J W BelmontC T Caskey
Aug 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·S KarlssonA W Nienhuis
Sep 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·O Danos, R C Mulligan
Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·W W KwokA D Miller
Dec 1, 1986·The Journal of Pediatrics·R D ChristensenG Rothstein
Nov 13, 1971·Lancet·N F MetcalfD J Moffatt
Aug 1, 1971·The Australian Journal of Experimental Biology and Medical Science·D Metcalf
Sep 1, 1993·The Journal of Experimental Medicine·P M LansdorpH Mayani
Sep 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·A A CardosoS C Clark
Feb 9, 1995·The New England Journal of Medicine·S IssaragrisilA Piankijagum
May 1, 1993·The American Journal of Pediatric Hematology/oncology·J E Wagner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

© 2021 Meta ULC. All rights reserved